K. Inamoto et al. / Tetrahedron 68 (2012) 7794e7798
7797
organic layer was washed with H2O (10 mLꢂ3) and dried over
MgSO4. The solvent was removed under the reduced pressure and
the residue was purified by SiO2 column chromatography using
AcOEt to give N-(4-methoxyphenyl)imidazole (3aa) (23.7 mg, 68%).
120e122 ꢀC). 1H NMR (400 MHz, CDCl3/TMS)
d
(ppm): 7.23 (br s,
1H), 7.26 (br s, 1H), 7.28 (dt, 2H, J¼9.3, 2.5 Hz), 7.61 (dt, 2H, J¼9.3,
2.5 Hz), 7.84 (br s, 1H); 13C{1H} NMR (150 MHz, CDCl3/TMS)
d
(ppm): 118.2,121.0, 123.0, 130.8, 133.0,135.5,136.4; LRMS (EI) m/z:
222 (Mþ); HRMS: calcd for C9H7BrN2: 221.9793, found: 221.9774; IR
(neat): 3853, 3753, 3587, 3503, 1696, 1653, 1559, 1507, 748,
4.4.2. Coupling reaction using Triton X-100 as a surfactant (Table 2,
entry 1, conditions B). Under an O2 atmosphere, a mixture of 4-
methoxyphenylboroic acid (1a, 60.8 mg, 0.40 mmol), imidazole
(2a, 13.6 mg, 0.20 mmol), Cu(OAc)2 (3.6 mg, 0.020 mmol), ligand I
(3.7 mg, 0.020 mmol), and Triton X-100 (38.8 mg, 0.060 mmol) in
H2O (4 mL) was stirred at room temperature for 24 h. The mixture
was diluted with brine and extracted with AcOEt (30 mLꢂ3). The
organic layer was washed with H2O (10 mLꢂ3) and dried over
MgSO4. The solvent was removed under the reduced pressure and
the residue was purified by SiO2 column chromatography using
AcOEt to give N-(4-methoxyphenyl)imidazole (3aa) (23.0 mg, 66%).
658 cmꢁ1
.
4.4.9. N-(4-Cyanophenyl)imidazole (3fa).19 Recrystallized from
Et2O/hexane, yellow prisms, mp 143e145 ꢀC (lit.19 mp
152e154 ꢀC). 1H NMR (400 MHz, CDCl3/TMS)
d
(ppm): 7.28 (br s,
1H), 7.35 (br s, 1H), 7.54 (d, 2H, J¼8.8 Hz), 7.81 (d, 2H, J¼8.8 Hz),
7.96 (br s, 1H); 13C{1H} NMR (150 MHz, CDCl3/TMS)
(ppm):
d
111.2, 117.7, 117.8, 121.4, 131.5, 134.2, 135.3, 140.5; LRMS (EI) m/z:
169 (Mþ); HRMS: calcd for C10H7N3: 169.0640, found: 169.0647;
IR (neat): 3903, 3753, 2960, 2854, 2372, 2359, 1733, 1559, 1271,
831 cmꢁ1
.
4.4.3. Coupling reaction using F-PEG as a surfactant (Table 2, entry 1,
conditions C). A mixture of Cu(OAc)2 (3.6 mg, 0.020 mmol), ligand
II (21.6 mg, 0.020 mmol), and F-PEG (0.25 g, 0.10 mmol) in MeOH
(1 mL) was heated to dissolve all the reagents added completely
and MeOH was removed under the reduced pressure. H2O (6 mL)
was added to the residue and then 4-methoxyphenylboroic acid
(1a, 60.8 mg, 0.40 mmol) and imidazole (2a, 13.6 mg, 0.20 mmol)
were added. The whole reaction mixture was stirred under an O2
atmosphere at room temperature for 24 h. The mixture was diluted
with brine and extracted with AcOEt (30 mLꢂ3). The organic layer
was washed with H2O (10 mLꢂ3) and dried over MgSO4. The sol-
vent was removed under the reduced pressure and the residue was
purified by SiO2 column chromatography using AcOEt to give N-(4-
methoxyphenyl)imidazole (3aa) (26.4 mg, 78%).
4.4.10. N-(4-Ethoxycarbonylphenyl)imidazole
lized from Et2O, colorless needles, mp 103e104 ꢀC (lit.18 mp
101e103 ꢀC); 1H NMR (400 MHz, CDCl3/TMS)
(ppm): 1.42 (t, 3H,
(3ga).18 Recrystal-
d
J¼7.1 Hz), 4.42 (q, 2H, J¼7.1 Hz), 7.25 (br s, 1H), 7.36 (br s, 1H),
7.47 (d, 2H, J¼8.3 Hz), 7.95 (br s, 1H), 8.17 (d, 2H, J¼8.3 Hz); 13C
{1H} NMR (125 MHz, CDCl3/TMS)
d (ppm): 14.4, 61.4, 117.9, 120.7,
129.5, 131.2, 131.6, 135.5, 140.7, 165.6; LRMS (EI) m/z: 216 (Mþ);
HRMS: calcd for C12H12N2O2: 216.0899, found: 216.0900; IR
(neat): 3852, 3674, 2926, 2853, 2374, 1733, 1652, 1508, 1369,
1122 cmꢁ1
.
4.4.11. N-(2-Methylphenyl)imidazole (3ha).20 Obtained as yellow
oil. 1H NMR (400 MHz, CDCl3/TMS)
(ppm): 2.19 (s, 3H), 7.06 (s,
1H), 7.21e7.36 (m, 5H), 7.59 (br s, 1H); 13C{1H} NMR (150 MHz,
d
4.4.4. N-(4-Methoxyphenyl)imidazole (3aa) .16 Obtained as a color-
CDCl3/TMS) d (ppm): 17.5, 120.5, 126.5, 126.8, 128.7, 129.3, 131.2,
less solid. 1H NMR (400 MHz, CDCl3/TMS)
d
(ppm): 3.85 (s, 3H), 6.98
133.8, 136.6, 137.4; LRMS (EI) m/z: 158 (Mþ); HRMS: calcd for
(d, 2H, J¼8.8 Hz), 7.18e7.26 (m, 2H), 7.30 (d, 2H, J¼8.8 Hz), 7.78 (br
C10H10N2: 158.0844, found: 158.0827; IR (neat): 3110, 2861, 1502,
s, 1H); 13C{1H} NMR (100 MHz, CDCl3/TMS)
d
(ppm): 55.4, 114.7,
1309, 1240, 1057, 963, 817, 761, 662 cmꢁ1
.
118.5, 123.0, 129.9, 130.5, 135.6, 158.4; LRMS (EI) m/z: 174 (Mþ);
HRMS: calcd for C10H10N2O: 174.0793, found: 174.0770; IR (neat):
4.4.12. N-(3-Aminophenyl)imidazole (3ia).18 Obtained as a yellow
solid. 1H NMR (400 MHz, CDCl3/TMS)
(ppm): 3.87 (br s, 2H),
3113, 2836, 1609, 1590, 1515, 1465, 1242, 1055, 828, 730 cmꢁ1
.
d
6.64e6.68 (m, 2H), 6.75e6.77 (m, 1H), 7.18e7.25 (m, 3H), 7.83 (br s,
1H); LRMS (EI) m/z: 159 (Mþ); HRMS: calcd for C9H9N3: 159.0796,
found: 159.0784; IR (neat): 3419, 3327, 3207, 1607, 1588, 1507,
4.4.5. N-(4-Methylphenyl)imidazole (3ba).16 Obtained as yellow oil.
1H NMR (400 MHz, CDCl3/TMS)
(ppm): 2.41 (s, 3H), 7.20 (br s, 1H),
7.25e7.28 (m, 5H), 7.83 (br s, 1H); 13C{1H} NMR (100 MHz, CDCl3/
d
1236 cmꢁ1
.
TMS)
d (ppm): 20.9, 118.3, 121.4, 130.2, 130.3, 135.0, 135.6, 137.4;
LRMS (EI) m/z: 158 (Mþ); HRMS: calcd for C10H10N2: 158.0844,
4.4.13. N-(4-Methoxyphenyl)benzimidazole (3ab).19 Obtained as
a colorless solid. 1H NMR (400 MHz, CDCl3/TMS)
(ppm): 3.89 (s,
found: 158.0827; IR (neat): 3113, 2861, 1520, 1487, 1303, 1112, 1056,
d
963, 810, 730 cmꢁ1
.
3H), 7.07 (d, 2H, J¼8.8 Hz), 7.29e7.35 (m, 2H), 7.41(d, 2H,
J¼8.8 Hz), 7.44e7.47 (m, 1H), 7.86e7.88 (m, 1H), 8.05 (s, 1H); 13C
4.4.6. N-Phenylimidazole (3ca).16 Obtained as colorless oil. 1H NMR
(400 MHz, CDCl3/TMS) (ppm): 7.22 (br s, 1H), 7.30 (br s, 1H),
7.35e7.41 (m, 3H), 7.46e7.51 (m, 2H), 7.87 (br s, 1H); 13C{1H} NMR
{1H} NMR (100 MHz, CDCl3/TMS)
d (ppm): 55.6, 110.3, 115.1,
d
120.5, 122.5, 123.5, 125.7, 129.1, 134.2, 142.5, 143.8, 159.3; LRMS
(EI) m/z: 224 (Mþ); HRMS: calcd for C14H12N2O: 224.0950, found:
224.0964.
(100 MHz, CDCl3/TMS)
d (ppm): 118.2, 121.4, 127.4, 129.8, 130.4,
135.6, 137.3; LRMS (EI) m/z: 144 (Mþ); HRMS: calcd for C9H8N2:
144.0687, found: 144.0677; IR (neat): 3407, 3116, 1718, 1600, 1507,
4.4.14. N-(4-Methoxyphenyl)-2-phenylimidazole (3ac). Obtained as
1303, 1056, 963, 757, 685 cmꢁ1
.
a colorless solid. 1H NMR (400 MHz, CDCl3/TMS)
d (ppm): 3.82 (s,
3H), 6.90(d, 2H, J¼8.8 Hz), 7.10 (s, 1H), 7.13 (d, 2H, J¼8.8 Hz),
4.4.7. N-(4-Chlorophenyl)imidazole (3da).17 Obtained as a colorless
solid. 1H NMR (400 MHz, CDCl3/TMS)
(ppm): 7.23 (br s, 1H), 7.26
(br s, 1H), 7.34 (d, 2H, J¼8.8 Hz), 7.46 (d, 2H, J¼8.8 Hz), 7.83 (br s,
7.22e7.26 (m, 4H), 7.39e7.42 (m, 2H); 13C{1H} NMR (100 MHz,
d
CDCl3/TMS) d (ppm): 55.4, 114.5, 123.1, 127.0, 128.1, 128.05, 128.08,
128.7, 130.3, 131.5, 146.7, 159.2; LRMS (EI) m/z: 250 (Mþ); HRMS:
1H); 13C{1H} NMR (100 MHz, CDCl3/TMS)
d
(ppm): 118.2, 122.7,
calcd for C16H14N2O: 250.1106, found: 250.1102.
130.1, 130.8, 133.2, 135.6, 135.9; LRMS (EI) m/z: 178 (Mþ); HRMS:
calcd for C9H375ClN2: 178.0298, found: 178.0292; IR (neat): 3407,
4.4.15. N-(4-Methoxyphenyl)-4-methylimidazole (3ad-1).14 and N-
(4-methoxyphenyl)-5-methylimidazole (3ad-2) Obtained as a color-
3116, 1718, 1600, 1507, 1303, 1056, 963, 757, 685 cmꢁ1
.
less solid. 1H NMR (400 MHz, CDCl3/TMS)
d (ppm): 2.13 (s, 1.2H),
4.4.8. N-(4-Bromophenyl)imidazole (3ea).18 Recrystallized from
AcOEt/hexane, colorless needles, mp 120e122 ꢀC (lit.18 mp
2.29 (s, 1.8H), 3.84 (s, 1.8H), 3.86 (s, 1.2H), 6.88 (s, 0.4H), 6.92 (s,
0.6H), 6.97 (d, 1.2H J¼9.0 Hz), 6.99 (d, 0.8H, J¼9.2 Hz), 7.20 (d, 0.8H,